Current scenario in inflammatory bowel disease: Drug development prospects.

CONCLUSIONS: Preclinical research on the complex IBD puzzle coupled with an active and vibrant research agenda in recent decades which might reveal patterns of pharmacological interactions instead of single potential drug targets. The increased collaboration between pharmaceutical companies, basic researchers and clinical researchers has the potential to bring us closer to developing an optimum pharmaceutical approach for the treatment of IBD. PMID: 25712643 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25712643?dopt=Abstract

Source: Pharmacological Reports - February 26, 2015 Category: Drugs & Pharmacology Authors: Chandel S, Prakash A, Medhi B Tags: Pharmacol Rep Source Type: research